Nautilus Biotechnology, Inc. Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss
Nautilus Biotechnology, Inc. (NAUT) had Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss of $341.00 thousand as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position, Accumulated Loss
us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss · last filed 2026-07-28
- 2026-06-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $341.00K.
- 2026-03-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $163.00K.
- 2025-12-31: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $13.00K.
- 2025-09-30: Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss $39.00K.
| Period end | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss |
|---|---|
| 2026-06-30 | $341.00K 10-Q · filed 2026-07-28 |
| 2026-03-31 | $163.00K 10-Q · filed 2026-04-28 |
| 2025-12-31 | $13.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $39.00K 10-Q · filed 2025-10-28 |
| 2025-06-30 | $0.00 10-Q · filed 2025-07-31 |
| 2025-03-31 | $0.00 10-Q · filed 2025-04-29 |
| 2024-12-31 | $294.00K 10-K · filed 2025-02-27 |
| 2024-09-30 | $69.00K 10-Q · filed 2024-10-29 |
| 2024-06-30 | $581.00K 10-Q · filed 2024-07-30 |
| 2024-03-31 | $770.00K 10-Q · filed 2024-04-30 |
| 2023-12-31 | $717.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.03M 10-Q · filed 2023-10-31 |
| 2023-06-30 | $2.39M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $1.22M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $1.89M 10-K · filed 2024-02-28 |
| 2022-09-30 | $1.88M 10-Q · filed 2022-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |